Stryker Corp (SYK) stock price, news and key stats

Price

Last close as of Sep 16, 2026. Delayed data; not a live quote.

Previous close

$281.50

Open

$280.34

Day range

$279.88 – $290.51

Volume

3.4M

About Stryker Corp

Latest SYK news

• In the News: Muer Yang on Private Equity’s Medical Device Push
  Private Equity · Sep 8, 2026

  Muer Yang, a prominent figure in the private equity sector, has recently highlighted the growing interest of private equity firms in the medical device industry. This trend is largely driven by the sector's potential for high returns, bolstered by an aging population and increasing demand for innovative healthcare solutions. Yang noted that private equity investments in medical devices have surged, as firms seek to capitalize on advancements in technology and the ongoing shift towards minimally invasive procedures. The implications for the market are significant. As private equity firms inject capital into medical device companies, there is potential for accelerated innovation and development of new products. This influx of funding can enhance competition within the industry, leading to improved patient outcomes and potentially lowering costs in the long term. However, it also raises concerns about the sustainability of such investments, particularly if firms prioritize short-term gains over long-term viability. Yang emphasized the importance of strategic partnerships between private equity firms and medical device manufacturers to navigate regulatory challenges and market dynamics effectively. As this trend continues, stakeholders across the healthcare spectrum will need to monitor the evolving landscape, as the intersection of private equity and medical devices could reshape the future of healthcare delivery.

• M&A Update: Is DME Still Attractive to Investors?
  IPO & M&A · Sep 4, 2026

  The durable medical equipment (DME) sector continues to draw attention from investors, despite recent fluctuations in the broader healthcare market. With an aging population and increasing demand for home healthcare solutions, DME companies are positioned to benefit from long-term growth trends. Recent mergers and acquisitions in the sector highlight ongoing interest, as firms seek to consolidate resources and expand their market reach. However, potential investors must navigate challenges such as regulatory scrutiny and reimbursement pressures that could impact profitability. The recent uptick in interest rates may also affect financing conditions for M&A deals, potentially slowing down transaction volumes. Analysts suggest that while the DME market remains attractive, investors should conduct thorough due diligence to assess individual company fundamentals and market positioning before committing capital. As the landscape evolves, strategic partnerships and innovative product offerings will likely play a crucial role in determining which companies emerge as leaders in the DME space.

• How better tail spend data can strengthen medical device compliance
  Yahoo Finance · Sep 1, 2026

  Medical device manufacturers are increasingly recognizing the importance of better tail spend data to enhance compliance and oversight of smaller suppliers not typically included in their main procurement programs. According to Oliver Norman, chief revenue officer at Nomia, a more granular understanding of tail spend can help manufacturers mitigate risks associated with regulatory compliance, quality control, and supply chain disruptions. This is particularly crucial in an industry where adherence to stringent regulations is paramount for maintaining market access and ensuring patient safety. The implications for the market are significant. As manufacturers adopt advanced analytics and data management strategies to track and evaluate tail spend, they can identify potential compliance issues before they escalate. This proactive approach not only strengthens regulatory adherence but also fosters stronger relationships with smaller suppliers, who often play a critical role in innovation and product development. By investing in better data management systems, medical device companies can enhance their operational efficiency and reduce the likelihood of costly recalls or regulatory fines, ultimately positioning themselves more favorably in a competitive landscape.

• Medtech M&A: choosing between private equity and strategic buyers
  Private Equity · Aug 27, 2026

  The medical technology (medtech) sector is experiencing a surge in mergers and acquisitions (M&A), with companies weighing the benefits of engaging private equity firms versus strategic buyers. Private equity firms are often drawn to medtech for their potential for high returns, leveraging financial engineering and operational improvements to enhance value. Conversely, strategic buyers, typically larger medtech companies, may offer synergies that can lead to accelerated growth and market expansion. As the landscape evolves, companies must consider their long-term goals when choosing between these two types of buyers. Private equity can provide the necessary capital and expertise to scale operations quickly, but may also impose a shorter investment horizon that prioritizes rapid returns. Strategic buyers, on the other hand, may be more patient and focused on integrating new technologies into their existing portfolios, potentially leading to more sustainable growth. Market implications are significant as the choice between these buyers can influence valuation metrics and deal structures. A preference for private equity could lead to increased competition for assets, driving up prices, while a strategic acquisition approach might foster a more collaborative environment, emphasizing innovation and product development. As the medtech sector continues to grow, understanding these dynamics will be crucial for stakeholders navigating this complex landscape.

• Spinal Surgery Devices Market Outlook Signals Expansion To $17.68 Billion Through 2030
  Market Outlook · Aug 27, 2026

  The spinal surgery devices market is on track for substantial growth, with projections indicating an increase from $13.37 billion in 2025 to $17.68 billion by 2030. This represents a compound annual growth rate (CAGR) of 5.7% during the forecast period. The market's expansion is driven by several factors, including the rising prevalence of spinal disorders, an increase in trauma cases, and advancements in surgical technology, particularly the adoption of robot-assisted spine surgeries. In the near term, the market is expected to grow from $13.37 billion in 2025 to $14.15 billion in 2026, reflecting a CAGR of 5.9%. This growth trajectory is indicative of a broader trend towards minimally invasive surgical techniques and outpatient procedures, which are gaining traction among healthcare providers and patients alike. Additionally, innovations in spinal implants and devices are enhancing recovery times and surgical outcomes, further propelling market demand. As the market evolves, stakeholders should closely monitor technological advancements and shifts in surgical practices that could influence competitive dynamics. The increasing focus on patient-centric care and faster recovery solutions will likely shape investment strategies and product development in the spinal surgery devices sector.

• Skull Clamp Market Report 2026 Market Outlook Supported By A Forecast 10.2% CAGR
  Market Outlook · Aug 26, 2026

  The skull clamp market is projected to experience a robust growth trajectory, with a compound annual growth rate (CAGR) of 10.2% through 2026, according to the latest report from Market Outlook. This growth is primarily driven by the increasing prevalence of neurological disorders and the rising number of surgical procedures requiring precise cranial stabilization. The demand for advanced surgical equipment, particularly in neurosurgery, is expected to bolster market expansion as healthcare facilities prioritize patient safety and surgical accuracy. Geographically, North America is anticipated to dominate the skull clamp market, attributed to the presence of well-established healthcare infrastructure and significant investments in medical technology. However, the Asia-Pacific region is expected to witness the fastest growth, fueled by improving healthcare access and rising healthcare expenditures in emerging economies. As hospitals and surgical centers adopt innovative technologies, manufacturers are likely to focus on product development and strategic partnerships to enhance their market position. Market implications suggest that stakeholders should prepare for increased competition as new entrants emerge, particularly in regions with growing healthcare demands. Additionally, advancements in materials and design aimed at improving patient comfort and surgical outcomes may shape future product offerings. Overall, the skull clamp market presents lucrative opportunities for investors and companies willing to adapt to evolving healthcare needs.

• Powered Surgical Instruments Market Outlook Signals Expansion To $3.33 Billion Through 2030
  Market Outlook · Aug 25, 2026

  The Powered Surgical Instruments market is poised for significant growth, projected to expand from a valuation of $2.59 billion in 2026 to $3.33 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.5%. This anticipated growth is largely driven by the increasing adoption of minimally invasive surgical techniques and heightened investments in advanced operating room technologies. As healthcare providers seek to enhance surgical precision and patient outcomes, the demand for powered surgical instruments is expected to rise correspondingly. Key factors contributing to this market expansion include the growing preference for cordless surgical instruments, which offer greater maneuverability and ease of use during procedures. Additionally, the surge in surgical procedures across various specialties is further fueling the demand for these advanced medical devices. As hospitals and surgical centers continue to upgrade their facilities to accommodate the latest technologies, the powered surgical instruments market is likely to see sustained investment and innovation, positioning it as a vital segment within the broader healthcare landscape.

• Prosthetics & Orthotics Market Outlook Highlights Strategic Opportunities Across The Industry
  Market Outlook · Aug 25, 2026

  The prosthetics and orthotics market is poised for significant growth, driven by advancements in technology and increasing demand for personalized healthcare solutions. According to recent analysis, the market is expected to expand at a compound annual growth rate (CAGR) of over 6% through the next five years. Key factors contributing to this growth include an aging population, rising incidences of diabetes and vascular diseases, and enhanced awareness of rehabilitation options among patients. Strategic opportunities within the industry are emerging as companies invest in innovative materials and smart technologies. The integration of artificial intelligence and robotics into prosthetic devices is expected to enhance functionality and user experience, thereby attracting a broader consumer base. Additionally, partnerships between manufacturers and healthcare providers are likely to facilitate better access to advanced orthotic solutions, particularly in underserved regions. Market implications are significant, as increased competition among key players could lead to price reductions and improved product offerings. Investors should monitor developments in regulatory approvals and reimbursement policies, which will play a crucial role in shaping market dynamics. As the industry evolves, stakeholders are encouraged to focus on research and development to capitalize on the growing demand for high-quality, adaptive prosthetic and orthotic solutions.

• Polymethyl Methacrylate (PMMA) Bone Cements Market Outlook Signals Expansion To $1.72 Billion Through 2030
  Market Outlook · Aug 24, 2026

  The global market for Polymethyl Methacrylate (PMMA) bone cements is projected to expand significantly, reaching an estimated value of $1.72 billion by 2030. This growth is driven by an increasing prevalence of orthopedic surgeries, particularly hip and knee replacements, as well as a rising geriatric population that is more susceptible to bone-related ailments. The demand for effective and reliable bone cement solutions is expected to rise, spurred by advancements in surgical techniques and materials. Market analysts attribute this expansion to several factors, including the growing adoption of minimally invasive surgical procedures and technological innovations in PMMA formulations that enhance their performance and biocompatibility. Additionally, the increasing incidence of osteoporosis and other degenerative bone diseases is likely to further fuel demand. As healthcare providers continue to prioritize patient outcomes, the focus on high-quality bone cements that offer improved mechanical properties and reduced complications will become paramount. From a market perspective, the anticipated growth in the PMMA bone cements sector may attract investments and drive competition among key players. Companies are expected to enhance their research and development efforts to introduce new products that meet evolving clinical needs. As the market evolves, stakeholders should monitor regulatory developments and shifts in healthcare policies that could impact the adoption and reimbursement of PMMA-based solutions.

• Polyether Ether Ketone (PEEK) Interbody Devices Market Outlook Highlights Strategic Opportunities Across The Industry
  Market Outlook · Aug 24, 2026

  The market for Polyether Ether Ketone (PEEK) interbody devices is poised for significant growth, driven by increasing demand for advanced biomaterials in spinal surgeries and orthopedic applications. According to a recent report, the global market for implant-grade PEEK polymer machining services is expected to expand as healthcare providers seek durable, biocompatible materials that enhance patient outcomes. The report highlights key strategic opportunities for manufacturers and suppliers, particularly in the development of innovative PEEK-based products that meet stringent regulatory standards. As the healthcare sector increasingly prioritizes minimally invasive procedures, PEEK's unique properties—such as high strength-to-weight ratio, chemical resistance, and radiolucency—make it an attractive choice for interbody devices. This trend is expected to stimulate investment in research and development, as companies aim to capitalize on the growing preference for PEEK over traditional materials like titanium and stainless steel. Furthermore, the rising incidence of spinal disorders and the aging population are likely to further drive demand, creating a favorable environment for market participants. Market implications are significant, with potential shifts in pricing strategies and supply chain dynamics as competition intensifies. Companies that can effectively leverage technological advancements in PEEK manufacturing and machining processes may gain a competitive edge. Additionally, partnerships between manufacturers and healthcare providers could facilitate the introduction of customized solutions, enhancing market penetration and customer loyalty in this evolving landscape.

All 13 articles in the app →

Index membership

• S&P 500 · Health Care

Related Health Care stocks

• AAgilent Technologies
• ABBVAbbVie
• ABTAbbott Laboratories
• ALGNAlign Technology
• AMGNAmgen
• BAXBaxter International
• BDXBecton Dickinson
• BIIBBiogen